2xir
From Proteopedia
(Difference between revisions)
m (Protected "2xir" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:2xir. | + | [[Image:2xir.png|left|200px]] |
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_2xir", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_2xir| PDB=2xir | SCENE= }} | {{STRUCTURE_2xir| PDB=2xir | SCENE= }} | ||
| Line 13: | Line 7: | ||
==About this Structure== | ==About this Structure== | ||
| - | [[2xir]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XIR OCA]. | + | [[2xir]] is a 1 chain structure of [[Vascular Endothelial Growth Factor Receptor]]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XIR OCA]. |
| + | |||
| + | ==See Also== | ||
| + | *[[Vascular Endothelial Growth Factor Receptor|Vascular Endothelial Growth Factor Receptor]] | ||
[[Category: Receptor protein-tyrosine kinase]] | [[Category: Receptor protein-tyrosine kinase]] | ||
[[Category: Hong, Y.]] | [[Category: Hong, Y.]] | ||
| Line 20: | Line 17: | ||
[[Category: Pinko, C.]] | [[Category: Pinko, C.]] | ||
[[Category: Wickersham, J.]] | [[Category: Wickersham, J.]] | ||
| + | [[Category: Angiogenesis]] | ||
| + | [[Category: Inhibitor]] | ||
| + | [[Category: Nucleotide-binding]] | ||
| + | [[Category: Phosphorylation]] | ||
| + | [[Category: Receptor]] | ||
| + | [[Category: Transferase]] | ||
| + | [[Category: Transmembrane]] | ||
Revision as of 14:02, 26 July 2012
CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH PF-00337210 (N,2-DIMETHYL-6-(7-(2-MORPHOLINOETHOXY) QUINOLIN-4-YLOXY)BENZOFURAN-3-CARBOXAMIDE)
About this Structure
2xir is a 1 chain structure of Vascular Endothelial Growth Factor Receptor. Full crystallographic information is available from OCA.
